HELIOS-A: 9-MONTH RESULTS FROM THE RANDOMIZED TREATMENT EXTENSION PERIOD OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY

被引：0

作者：

Obici, Laura ^{[1
]}

Polydefkis, Michael ^{[2
]}

Gonzalez-Duarte, Alejandra ^{[3
]}

Waddington-Cruz, Marcia ^{[4
]}

Sekijima, Yoshiki ^{[5
]}

Gillmore, Julian D. ^{[6
]}

Yureneva, Elena ^{[7
]}

Badri, Prajakta ^{[7
]}

Chen, Chongshu ^{[7
]}

Sweetser, Marianne ^{[7
]}

Vest, John ^{[7
]}

Adams, David ^{[8
]}

机构：

[1] IRCCS Fondat, Amyloidosis Res & Treatment Ctr, Policlin San Matteo, Pavia, Italy

[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA

[3] Natl Inst Med Sci & Nutr Salvador Zubiran INCMNSZ, Neurol, Mexico City, DF, Mexico

[4] Fed Univ Rio De Janeiro UFRJ, Clementino Fraga Filho Univ Hosp, Rio De Janeiro, Brazil

[5] Shinshu Univ, Dept Med, Neurol Rheumatol, Sch Med, Matsumoto, Nagano, Japan

[6] UCL, Royal Free Hosp, Natl Amyloidosis Ctr, London, England

[7] Alnylam Pharmaceut, Cambridge, MA USA

[8] Univ Paris Saclay, Neurol Dept, APHP, CHU Bicetre, Paris, France

来源：

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2023年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S40 / S40

页数：1

共 50 条

[1] HELIOS-A: 9-month results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
Adams, Davide
Tournev, Ivailo
Taylor, Mark
Coelho, Teresa
Plante-Bordeneuve, Violaine
Berk, John
Gonzalez-Duarte, Alejandra
Gillmore, Julian
Low, Soon-Chai
Sekijima, Yoshiki
Obici, Laura
Blakesley, Rick
Arum, Seth
Shilling, Rebecca
Vest, John
Polydefkis, Michael
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
[2] HELIOS-A: 9-month Results from the Phase 3 Study of Vutrisiran in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy
Adams, David
Tournev, Ivailo L.
Taylor, Mark S.
Coelho, Teresa
Plante-Bordeneuve, Violaine
Berk, John L.
Gonzalez-Duarte, Alejandra
Gillmore, Julian D.
Low, Soon-Chai
Sekijima, Yoshiki
Obici, Laura
Blakesley, Rick
Arum, Seth
Shilling, Rebecca
Vest, John
Polydefkis, Michael
NEUROLOGY, 2021, 96 (15)
[3] HELIOS-A: 9-month results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
Adams, David
Tournev, Ivailo
Taylor, Mark
Coelho, Teresa
Plante-Bordeneuve, Violaine
Berk, John
Gonzalez-Duarte, Alejandra
Gillmore, Julian
Low, Soon-Chai
Sekijima, Yoshiki
Obici, Laura
Blakesley, Rick
Arum, Seth
Shilling, Rebecca
Vest, John
Polydefkis, Michael
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2021, 26 (03) : 309 - 309
[4] HELIOS-A: 9-month subgroup analyses and exploratory efficacy results from the phase 3 study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
Remiche, Gauthier
Adams, David
Taylor, Mark S.
Plante-Bordeneuve, Violaine
Berk, John L.
Gonzales-Duarte, Alejandra
Gillmore, Julian D.
Low, Soon Chai
Sekijima, Yoshiki
Obici, Laura
Blakesley, Rick
Arum, Seth
Shilling, Rebecca
Vest, John
Polydefkis, Michael
ACTA CARDIOLOGICA, 2022, 77 : 14 - 14
[5] HELIOS-A: RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
Gonzalez-Duarte, Alejandra
Adams, David
Tournev, Ivailo
Taylor, Mark
Coelho, Teresa
Plante-Bordeneuve, Violaine
Berk, John
Gillmore, Julian David
Low, Soon-Chai
Sekijima, Yoshiki
Obici, Laura
Chen, Chongshu
Badri, Prajakta
Arum, Seth
Vest, John
Polydefkis, Michael
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 302 - 302
[6] HELIOS-A: NINE-MONTH RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
Adams, David
Tournev, Ivailo
Taylor, Mark
Coelho, Teresa
Plante-Bordeneuve, Violaine
Berk, John
Gonzalez-Duarte, Alejandra
Gillmore, Julian
Low, Soon-Chai
Sekijima, Yoshiki
Obici, Laura
Blakesley, Rick
Arum, Seth
Shilling, Rebecca
Vest, John
Polydefkis, Michael
MUSCLE & NERVE, 2021, 64 : S54 - S55
[7] HELIOS-A: IMPACT OF VUTRISIRAN ON QUALITY OF LIFE AND FUNCTIONAL STATUS IN HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
Ajroud-Driss, Senda
Berk, John
Adams, David
Gillmore, Julian D.
Lin, Kon-Ping
Kale, Parag
Koike, Haruki
Aldinc, Emre
Chen, Chongshu
Vest, John
Obici, Laura
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2022, 27 : S6 - S6
[8] HELIOS-A: 18-MONTH EXPLORATORY CARDIAC RESULTS FROM THE PHASE 3 STUDY OF VUTRISIRAN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS
Mussinelli, Roberta
Garcia-pavia, Pablo
Gillmore, Julian D.
Kale, Parag
Berk, John L.
Maurer, Mathew S.
Conceicao, Isabel
Dicarli, Marcelo
Solomon, Scott
Chen, Chongshu
Arum, Seth
Vest, John
Grogan, Martha
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
[9] HELIOS-A: IMPACT OF VUTRISIRAN ON QUALITY OF LIFE AND FUNCTIONAL STATUS IN HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS
Ajroud-Driss, Senda
Berk, John L.
Adams, David
Gillmore, Julian
Lin, Kon-Ping
Kale, Parag
Koike, Haruki
Aldinc, Emre
Chen, Chongshu
Vest, John
Obici, Laura
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2023, 28 : S40 - S41
[10] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
Tina Nie
Young-A Heo
Matt Shirley
Drugs, 2023, 83 : 1425 - 1432

← 1 2 3 4 5 →